Indication
for the treatment of schizophrenia in adult patients

Medicine details

Medicine name:
cariprazine (Reagila)
SMC ID:
SMC2137
Pharmaceutical company
Recordati Pharmaceuticals
BNF chapter
Central nervous system
Submission type
Full submission
Status
Advice due date:
13 May 2019
SMC meeting date:
02 April 2019
Patient group submission deadline:
04 March 2019